Teresa Company Messa: ”Evolution, Commitment, and Innovation” Perfectly Sum up Last Week’s Event
Teresa Company Messa, Market Development Manager at Werfen, shared on LinkedIn:
”Evolution, commitment, and innovation
Three big words, but ones that perfectly sum up last week’s event: the launch of the 70 Series, a new generation of analyzers that mark another step forward in our mission to advance hemostasis diagnostics.
And there could be no better setting than La Pedrera.
Just as Gaudà challenged the limits of his time to transform architecture, we continue to push the limits of technology to transform diagnostics.
And for those of you who are not part of this world, you may ask yourselves: what does this have to do with me?
Everything.
Because behind every sample there is a person, and that person could be you, it could be me.
At Werfen, we work every day with a firm commitment to ensuring the highest quality, accuracy, and service for laboratory professionals and, ultimately, for patients.”
Stay updated with Hemostasis Today.
-
Jul 4, 2026, 10:56Alec Van Gelder: Novo Nordisk Opens Global Patient Advocacy Role for Haemoglobinopathies
-
Jul 4, 2026, 09:44Ettore Nicolini: Optimizing First-Pass Reperfusion in Basilar Artery Occlusion
-
Jul 4, 2026, 09:15Niroshani Young: The Essentials of Safe Blood Component Transfusion
-
Jul 4, 2026, 08:48Satarupa Choudhuri: Personalizing Anticoagulation Duration After VTE
-
Jul 4, 2026, 07:41Reem Alotaibi: Hexokinase as a Regulator of Platelet Metabolism and Function
-
Jul 4, 2026, 07:10Andrew Zapfel: A New WHO Framework for Newborn Screening in Low and Middle-Income Countries
-
Jul 3, 2026, 23:08For Jatinder Minhas, The Strength of Simulation Training Is Learning Together Across Disciplines – ESO
-
Jul 3, 2026, 22:47Khaled Musallam: Caring for Women with Thalassemia From Puberty to Pregnancy and Beyond
-
Jul 3, 2026, 21:25Matteo Foschi: Happy to Join the Italian Stroke Association Summer School